Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase®.

Source: Cephalalgia 2023 Apr; 43(4). doi: 10.1177/03331024231158083Authors: Noseda R, Bedussi F, Gobbi C, Ceschi A, Zecca C

Safety data on the use of migraine preventive monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) system in pregnancy are limited.

Pubmed ID: https://pubmed.ncbi.nlm.nih.gov/36855950/